Technology from Salish Bioscience utilizes groundbreaking molecular biology to address the unmet need for greater sensitivity in cancer diagnostics.

Our liquid biopsy process results in the ability to detect circulating tumor DNA fragments at very low mutant allele frequencies, thereby enabling higher levels of diagnostic sensitivity than currently available technologies.